TLR9 signals after translocating from the ER to CpG DNA in the lysosome

Nature Immunology

Volumn 5, Issue 2, 2004, Pages 190-198

  Latz, Eicke ^a   Schoenemeyer, Annett ^a   Visintin, Alberto ^a   Fitzgerald, Katherine A ^a   Monks, Brian G ^a   Knetter, Cathrine F ^a,b   Lien, Egil ^a   Nilsen, Nadra J ^b   Espevik, Terje ^b   Golenbock, Douglas T ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIGAND; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL STRUCTURE; CELL TRANSPORT; CONTROLLED STUDY; CPG ISLAND; DATA ANALYSIS; DNA TRANSFER; ENDOPLASMIC RETICULUM; ENDOSOME; GENE TRANSLOCATION; HUMAN; HUMAN CELL; LIGAND BINDING; LYSOSOME; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CPG ISLANDS; DENDRITIC CELLS; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM; HUMANS; LUMINESCENT PROTEINS; LYSOSOMES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 10744219675     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1028     Document Type: Article

References (36)

1. Tokunaga, T. et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and anti-tumor activity. J. Natl. Cancer Inst. 72, 955-962 (1984).
2. Yamamoto, S., Kuramoto, E., Shimada, S. & Tokunaga, T. In vitro augmentation of natural killer cell activity and production of interferon-α/β and γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 79, 866-873 (1988).
3. Krieg, A.M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549 (1995).
4. Agrawal, S. & Kandimalla, E.R. Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol. Med. 8, 114-121 (2002).
5. Krieg, A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760 (2002).
6. Gordon, S. Pattern recognition receptors: doubling up for the innate immune response. Cell 111, 927-930 (2002).
7. Hemmi, H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
8. Bauer, S. et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98, 9237-9242 (2001).
9. Tauszig, S., Jouanguy, E., Hoffmann, J.A. & Imler, J.L. Toll-related receptors and the control of antimicrobial peptide expression in Drosophila. Proc. Natl. Acad. Sci. USA 97, 10520-10525 (2000).
10. Weber, A.N. et al. Binding of the Drosophila cytokine Spatzle to Toll is direct and establishes signaling. Nat. Immunol. 4, 794-800 (2003).
11. Manzel, L. & Macfarlane, D.E. Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide. Antisense Nucleic Acid Drug. Dev. 9, 459-464 (1999).
12. Yamamoto, T., Yamamoto, S., Kataoka, T. & Tokunaga, T. Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity. Microbiol. Immunol. 38, 831-836 (1994).
13. Gursel, I., Gursel, M., Ishii, K.J. & Klinman, D.M. Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides. J. Immunol. 167, 3324-3328 (2001).
14. Hacker, H. et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17, 6230-6240 (1998)
15. Yi, A.K. et al. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J. Immunol. 160, 4755-4761 (1998).
16. Ahmad-Nejad, P. et al. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958-1968 (2002)
17. Takeshita, F. et al. Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167, 3555-3558 (2001).
18. Latz, E. et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277, 47834-47843 (2002).
19. Hornung, V. et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537 (2002).
20. Kadowaki, N. et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869 (2001).
21. Stenmark, H., Aasland, R. & Driscoll, P.C. The phosphatidylinositol 3-phosphate-binding FYVE finger. FEBS Lett. 513, 77-84 (2002).
22. Helenius, A. & Aebi, M. Intracellular functions of N-linked glycans. Science 291, 2364-2369 (2001).
23. Desjardins, M. ER-mediated phagocytosis: a new membrane for new functions. Nat. Rev. Immunol. 3, 280-291 (2003).
24. Gagnon, E. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119-131 (2002).
25. Lund, J., Sato, A., Akira, S., Medzhitov, R. & Iwasaki, A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513-520 (2003).
26. Flo, T.H. et al. Involvement of Toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem. 277, 35489-35495 (2002).
27. Underhill, D.M. et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811-815 (1999).
28. Lee, J. et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 100, 6646-6651 (2003).
29. Mellman, I. Endocytosis and molecular sorting. Annu. Rev. Cell. Dev. Biol. 12, 575-625 (1996).
30. Garin, J. et al. The phagosome proteome: insight into phagosome functions. J. Cell. Biol. 152, 165-180 (2001).
31. Guermonprez, P. et al. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397-402 (2003).
32. Houde, M. et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 425, 402-406 (2003).
33. Okazaki, Y., Ohno, H., Takase, K., Ochiai, T. & Saito, T. Cell surface expression of calnexin, a molecular chaperone in the endoplasmic reticulum. J. Biol. Chem. 275, 35751-35758 (2000).
34. Johnson, S., Michalak, M., Opas, M. & Eggleton, P. The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell. Biol. 11, 122-129 (2001).
35. Leadbetter, E.A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607 (2002).
36. Chow, A., Toomre, D., Garrett, W. & Mellman, I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418, 988-994 (2002).